Product Code: SR112023A5758
Market Overview:
The global brain monitoring market size reached US$ 6.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.9 Billion by 2028, exhibiting a growth rate (CAGR) of 6.6% during 2023-2028.
Brain monitoring is a process that is widely utilized for monitoring neural and electrical activity by investigating the functionalities and structure of the brain. The procedure is done by using several brain monitoring devices, such as intracranial pressure monitors, electroencephalography (EEG) devices and magnetoencephalography (MEG), that track the brain functions effectively. By investigating the structure and function of the brain under the influence of anesthesia, these devices acquire the bilateral data and process the EEG signals to accurately diagnose neurological conditions. Most of these devices are lightweight, portable, compact, cost-effective and powered by a single AAA battery. The most common neurological disorders that are monitored and treated with brain monitoring solutions include dementia, Huntington's disease, headache disorders, multiple sclerosis, epilepsy, Parkinson's disease, neuro infections, stroke, and cerebral palsy.
Brain Monitoring Market Trends:
The market is primarily driven by the increasing prevalence of neurodegenerative diseases among the masses. This can be attributed to the considerable growth in the geriatric population that is susceptible to these disorders. With the advent of wireless technology, continual technological advancements and the miniaturization of medical devices, the size of various brain monitoring devices has been greatly reduced, which, in turn, is resulting in the greater adoption of these devices. In line with this, the rising demand for non-invasive and minimally invasive procedures is providing an impetus to the market growth. Apart from this, the growing healthcare expenditure is also creating a positive outlook for the market on the global level. Some of the other factors that are further contributing to the market growth include continual developments in the healthcare infrastructure and extensive research and development (R&D) activities conducted by key players.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global brain monitoring market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, procedure, application and end user.
Breakup by Product Type:
Electroencephalography (EEG) Devices
Magnetoencephalography (MEG) Devices
Transcranial Doppler (TCD) Devices
Intracranial Pressure (ICP) Monitors
Cerebral Oximeters
Magnetic Resonance Imaging (MRI) Devices
Computerized Tomography (CT) Devices
Positron Emission Tomography (PET) Devices
Sleep Monitoring Devices
Electromyography (EMG) Devices
Accessories
Breakup by Procedure:
Invasive
Non-invasive
Breakup by Application:
Parkinson's Disease
Traumatic Brain Injury (TBI)
Epilepsy
Dementia
Sleep Disorders
Others
Breakup by End User:
Hospitals
Diagnostic Centers
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced Brain Monitoring Inc., Cadwell Industries Inc., Compumedics Limited (D & DJ Burton Holdings Pty Ltd.), Dragerwerk AG & Co. KGaA, Elekta, General Electric Company, Integra LifeSciences, Koninklijke Philips N.V., Masimo, Medtronic plc, Natus Medical Incorporated, Nihon Kohden Corporation, Siemens Healthineers AG (Siemens AG) and Spiegelberg GmbH & Co. KG.
Key Questions Answered in This Report:
- How has the global brain monitoring market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global brain monitoring market?
- What are the key regional markets?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the procedure?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global brain monitoring market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Brain Monitoring Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Electroencephalography (EEG) Devices
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Magnetoencephalography (MEG) Devices
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Transcranial Doppler (TCD) Devices
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Intracranial Pressure (ICP) Monitors
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Cerebral Oximeters
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Magnetic Resonance Imaging (MRI) Devices
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
- 6.7 Computerized Tomography (CT) Devices
- 6.7.1 Market Trends
- 6.7.2 Market Forecast
- 6.8 Positron Emission Tomography (PET) Devices
- 6.8.1 Market Trends
- 6.8.2 Market Forecast
- 6.9 Sleep Monitoring Devices
- 6.9.1 Market Trends
- 6.9.2 Market Forecast
- 6.10 Electromyography (EMG) Devices
- 6.10.1 Market Trends
- 6.10.2 Market Forecast
- 6.11 Accessories
- 6.11.1 Market Trends
- 6.11.2 Market Forecast
7 Market Breakup by Procedure
- 7.1 Invasive
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Non-invasive
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Application
- 8.1 Parkinson's Disease
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Traumatic Brain Injury (TBI)
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Epilepsy
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Dementia
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Sleep Disorders
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Diagnostic Centers
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Advanced Brain Monitoring Inc.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.2 Cadwell Industries Inc.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Compumedics Limited (D & DJ Burton Holdings Pty Ltd.)
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.4 Dragerwerk AG & Co. KGaA
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Elekta
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 General Electric Company
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Integra LifeSciences
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Koninklijke Philips N.V.
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Masimo
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 .Medtronic plc
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Natus Medical Incorporated
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
- 15.3.12 Nihon Kohden Corporation
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.12.3 Financials
- 15.3.12.4 SWOT Analysis
- 15.3.13 Siemens Healthineers AG (Siemens AG)
- 15.3.13.1 Company Overview
- 15.3.13.2 Product Portfolio
- 15.3.13.3 Financials
- 15.3.13.4 SWOT Analysis
- 15.3.14 Spiegelberg GmbH & Co. KG
- 15.3.14.1 Company Overview
- 15.3.14.2 Product Portfolio